Avid Radiopharmaceuticals
Eric Wang is a skilled professional in the field of clinical supply and commercial manufacturing, currently serving as a Senior Associate at Avid Radiopharmaceuticals since April 2019. Prior roles at Avid included positions as a Commercial Manufacturing Intern and a Quality Co-op. Eric's experience also encompasses a Quality Co-op at DSM from September 2017 to March 2018 and a Safety Pharmacology Co-op at GlaxoSmithKline Pharma GmbH from September 2016 to March 2017. Eric Wang holds a Master of Science in Bioengineering and Biomedical Engineering from Drexel University, earned between 2016 and 2020.
Avid Radiopharmaceuticals
1 followers
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.